Abstract
Cystic fibrosis (CF) is a disorder characterized by elevated sweat electrolytes and thick mucous secretions due to abnormal chloride permeability in epithelial tissues. The gene responsible for this disease, the CF transmembrane conductance regulator (CFTR) was identified by a positional cloning approach 3 years ago. Since that time, over two hundred mutations have been found in CFTR genes from affected individuals. Analysis of these disease-associated mutations has provided new insight into the etiology of this disease and into the mechanisms of epithelial electrolyte secretion.
Similar content being viewed by others
References
Abeliovich, D., Lavon, I. P., Lerer, I., Cohen, T., Springer, C., Avital, A., and Cutting, G. R. (1992). Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population,Am. J. Hum. Genet. 51, 951–956.
Boat, T. F., Welsh, M. J., and Beaudet, A. L. (1989). Cystic Fibrosis. InThe Metabolic Basis of Inherited Disease (Scriver, C. L., Beaudet, A. L., Sly W. S., and Valle, D., eds.), McGraw-Hill, New York, pp. 2649–2680.
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souzo, D. W., White, G. A., O'Riordan, C. R., and Smith, A. E. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis,Cell 63, 827–834.
Chu, C-S., Trapnell, B. C., Murtagh, J. J., Moss, J., Dalemans, W., Jallat, S., Mercenier, A., Pavirani, A., Lecocq, J-P., Cutting, G. R., Guggino, W. B., and Crystal, R. G. (1991). Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium,EMBO J. 10, 1355–1363.
Collins, F. S. (1992). Cystic fibrosis: molecular biology and therapeutic implications,Science 256, 774–779.
Cutting, G. R., Kasch, L. M., Rosenstein, B. J., Zielenski, J., Tsui, L-C., Antonarakis, S. E., and Kazazian, H. H. Jr (1990b). A cluster of Cystic Fibrosis mutations in the first nucleotide binding domain of the CFTR protein,Nature (London) 346, 366–369.
Cutting, G. R., Kasch, L. M., Rosenstein, B. J., Tsui, L-C., Kazazian, H. H., Jr., and Antonarakis, S. E. (1990b). Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease,New Eng. J. Med. 323, 1685–1689.
Cutting, G. R., Curristin, S. M., Nash, E., Rosenstein, B. J., Lerer, I., Abeliovich, D., Hill, A., and Graham, C. (1992). Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occurs in common among Caucasians,Am. J. Hum. Genet. 50, 1185–1194.
Cystic Fibrosis Genetic Analysis Consortium (1990). Worldwide survey of the deltaF508 mutation—Report from the Cystic Fibrosis Genetic Analysis Consortium (CFGAC)Am. J. Hum. Genet. 47, 354–359.
Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavirani, A., Lecocq, J-P., and Lazdunski, M. (1991). Altered chloride ion channel kinetics associated with the deltaF508 cystic fibrosis mutation,Nature 354, 526–528.
Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive,Nature (London) 358, 761–764.
Drumm, M. L., Wilkinson, D. J., Smit, L. S., Worrell, R. T., Strong, T. V., Frizzell, R. A., Dawson, D. C., and Collins, F. S. (1991). Chloride conductance expressed by deltaF508 and other mutant CFTRs inXenopus oocytes,Science 254, 1797–1799.
European Working Group of CF Genetics (EWGCFG) (1990). Gradient of distribution in Europe of the major CF mutation and of its associated haplotype,Hum. Genet. 85, 436–441.
Granell, J., Solera, J., Carrasco, S., and Molano, J. (1992). Identification of a nonframeshift 84-bp deletion in exon 13 of the cystic fibrosis gene,Am. J. Hum. Genet. 50, 1022–1026.
Hamosh, A., and Cutting, G. R. (1992). Genotype/phenotype relationships in cystic fibrosis. InCurrent Topics in Cystic Fibrosis (Dodge, J. A., Brock, D. J. H., and Widdicombe, J. H., eds.), Wiley, Chichester, in press.
Hamosh, A., Trapnell, B. C., Zeitlin, P. L., Montrose-Rafizadeh, C., Rosenstein, B. J., Crystal, R. G., and Cutting, G. R. (1991). Severe deficiency of CFTR mRNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis,J. Clin. Invest. 88, 1880–1885.
Hamosh, A., King, T. M., Rosenstein, B. J., andet al. (1992a). Cystic fibrosis patients bearing the common missense mutation Gly → Asp at codon 551 and the deltaF508 are indistinguishable from deltaF508 homozygotes except for decreased risk of meconium ileus,Am. J. Hum. Genet. 51, 245–250.
Hamosh, A., Rosenstein, B. J., and Cutting, G. R. (1992b). CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in respiratory epithelial cells,Hum. Mol. Genet. 1, 542–544.
Kerem, B., Zielenski, J., Markiewicz, D., Bozon, D., Gazit, E., Yahaf, J., Kennedy, D., Riordan, J. R., Collins, F. S., Rommens, J. M., and Tsui, L-C. (1990). Identification of mutations in regions corresponding to the 2 putative nucleotide (ATP)-binding folds of the cystic fibrosis gene,Proc. Natl. Acad. Sci. USA 87, 8447–8451.
Kerem, E., Corey, M., Kerem, B-S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L-C., and Durie, P. (1990). The relation between genotype and phenotype in cystic fibrosis—analysis of the most common mutation (ΔF508),New Engl. J. Med. 323, 1517–1522.
Knowles, M. R., Barnett, T. B., McConkie-Rosell, A., Sawyer, C., and Kahler, S. G. (1989). Mild cystic fibrosis in a consanguineous family,Ann. Int. Med. 110, 599–605.
Kobayashi, K., Knowles, M. R., Boucher, R. C., O'Brien, W. E., and Beaudet, A. L. (1990). Benign missense variations in the cystic fibrosis gene,Am. J. Hum. Genet. 47, 611–615.
Kristidis, P., Bozon, D., Corey, M., Markiewicz, D., Rommens, J., Tsui, L-C., and Durie, P. (1992). Genetic determination of exocrine pancreatic function in cystic fibrosis,Am. J. Hum. Genet. 50, 1178–1184.
McIntosh, I., and Cutting, G. R. (1992). Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis,FASEB J. 6, 2775–2782.
Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J. L., Drumm, M. L., lannuzzi, M. C., Collins, F. S., and Tsui, L-C. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA,Science 245, 1066–1073.
Rommens, J. M., lannuzzi, M. C., Kerem, B., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., Zsiga, M., Buchwald, M., Riordan, J. R., Tsui, L-C., and Collins, F. S. (1989). Identification of the cystic fibrosis gene: chromosome walking and jumping,Science 245, 1059–1065.
Rozen, R., De Braekeleer, M., Daigneault, J., Ferreira-Rajabi, L., Gerdes, M., Lamoureux, L., Aubin, G., Simard, F., Fujiwara, T. M., and Morgan, K. (1992). Cystic fibrosis mutations in French Canadians: Three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis,Am. J. Med. Genet. 42, 360–364.
Sangiuolo, F., Novelli, G., Murru, S., and Dallapiccola, B. (1991). A serine-to-arginine (AGT-to-CGT) mutation in codon 549 of the CFTR gene in an Italian patient with severe cystic fibrosis,Genomics 9, 788–789.
Shoshani, T., Augarten, A., Gazit, E., Bashan, N., Yahav, Y., Rivlin, Y., Tal, A., Seret, H., Yaar, L., Kerem, E., and Kerem, B-S. (1992). Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with severe disease presentation,Am. J. Hum. Genet. 50, 222–228.
Strong, T. V., Smit, L. S., Turpin, S. V., Cole, J. L., Tom Hon, C., Markiewicz, D., Craig, M. W., Rosenow, E. C. III, Tsui, L-C., Knowles, M. R., and Collins, F. S. (1991). Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels,New Engl. J. Med. 325, 1630–1634.
Zeitlin, P. L., Crawford, I., Lu, L., Woek, S., Cohen, M. E., Donowitz, M., Montrose, M. H., Hamosh, A., Cutting, G. R., Gruenert, D., Huganir, R., Maloney, P., and Guggino, W. B. (1992). CFTR protein expression in primary and cultured epithelia,Proc. Natl. Acad. Sci. USA 89, 344–347.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cutting, G.R. Spectrum of mutations in cystic fibrosis. J Bioenerg Biomembr 25, 7–10 (1993). https://doi.org/10.1007/BF00768062
Issue Date:
DOI: https://doi.org/10.1007/BF00768062